H. Kobashi

发表

Wilson's disease masquerading as nonalcoholic steatohepatitis

G. Yamada, M. Kawanaka, S. Mahmood, 2009, North American journal of medical sciences.

Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoprotein

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Journal of gastroenterology and hepatology.

A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

M. Kurosaki, N. Izumi, T. Sohda, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group

M. Kurosaki, N. Izumi, T. Sohda, 2022, Journal of viral hepatitis.

Serum levels of platelet‐derived growth factor‐BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure

H. Shiraha, A. Takaki, K. Nouso, 2011, Journal of gastroenterology and hepatology.

Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B

Y. Karino, M. Sata, N. Izumi, 2010, Hepatology international.

Efficacy and safety of entecavir in nucleoside‐naive, chronic hepatitis B patients: Phase II clinical study in Japan

O. Yokosuka, Y. Shiratori, F. Imazeki, 2009, Journal of gastroenterology and hepatology.

Diagnostic Accuracy of Laparoscopic Liver Biopsy in Chronic Liver Diseases, Comparison of Laparoscopic and US‐Guided Liver Biopsy Results

H. Shiraha, Kazuhide Yamamoto, N. Omori, 1995 .

Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib

H. Shiraha, H. Hagihara, A. Takaki, 2018, Journal of gastroenterology and hepatology.

Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma

K. Kuwaki, A. Takaki, Shinichiro Nakamura, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

A. Takaki, Shinichiro Nakamura, K. Nouso, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Kazuhide Yamamoto, Y. Miyake, H. Kobashi, 2009, Journal of Gastroenterology.

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.

M. Kurosaki, N. Izumi, H. Marusawa, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

M. Kurosaki, N. Izumi, T. Sohda, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis

M. Kurosaki, N. Izumi, T. Sohda, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy

M. Kurosaki, N. Izumi, H. Marusawa, 2022, JGH open : an open access journal of gastroenterology and hepatology.

A prospective and comparative cohort study on efficacy and drug resistance during long‐term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis

Y. Shiratori, A. Takaki, Kazuhide Yamamoto, 2008, Journal of gastroenterology and hepatology.

Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort.

Y. Shiratori, K. Fujio, Y. Iwasaki, 2005, Acta medica Okayama.

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection q

N. Hayashi, K. Chayama, O. Yokosuka, 2010 .

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.

K. Tanikawa, N. Hayashi, K. Chayama, 2010, Journal of hepatology.

Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B

K. Tanikawa, N. Hayashi, M. Sata, 2009, Hepatology international.

Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease

H. Shiraha, A. Takaki, K. Nouso, 2010, Journal of Gastroenterology.

Treatment strategy for chronic hepatitis B and C based on the guidelines

H. Kobashi, 2010 .

Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience

Y. Shiratori, Kazuhide Yamamoto, D. Tanioka, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver

K. Yamamoto, H. Kobashi, M. Ohmoto, 1994, Hepatology.

Gastrointestinal stromal tumors in the duodenum show increased contrast enhancement compared with those in the stomach on computed tomography

M. Iwamuro, M. Inoue, H. Kobashi, 2022, Molecular and clinical oncology.

Evolution of prognostic factors in hepatocellular carcinoma in Japan

H. Shiraha, K. Kuwaki, H. Hagihara, 2010, Alimentary pharmacology & therapeutics.

Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non‐acetaminophen‐related fulminant hepatic failure

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2007, Journal of gastroenterology and hepatology.

High expression of a vascular stricture‐related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long‐term survival after tolvaptan administration for liver cirrhosis

H. Shiraha, A. Takaki, Y. Takeuchi, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Recommendation of lamivudine‐to‐entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial

H. Nomura, K. Matsuura, F. Sugauchi, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus

M. Kurosaki, N. Izumi, H. Marusawa, 2021, Hepatology communications.

Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score

M. Kurosaki, N. Izumi, H. Marusawa, 2020, Scientific Reports.

Accumulation of multiple T‐cell clonotypes in the liver of primary biliary cirrhosis

T. Tsuji, R. Okamoto, K. Yamamoto, 1997, Hepatology.

Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

M. Kurosaki, N. Izumi, H. Marusawa, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Autoimmune hepatitis with acute presentation in Japan.

A. Takaki, T. Yasunaka, F. Ikeda, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Colorectal Manifestation of Follicular Lymphoma.

K. Takata, T. Yoshino, M. Iwamuro, 2016, Internal medicine.

Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid

A. Takaki, Kazuhide Yamamoto, Y. Takeuchi, 2011, Journal of gastroenterology and hepatology.

Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population

Kazuhide Yamamoto, T. Yasunaka, F. Ikeda, 2009, Journal of Gastroenterology.

Receptor-mediated endocytosis of chemically modified albumins by sinusoidal endothelial cells and Kupffer cells in rat and human liver.

Kazuhide Yamamoto, T. Tsuji, K. Yamamoto, 2008, Liver.

Activated liver macrophages in human liver diseases

T. Tsuji, R. Okamoto, K. Yamamoto, 1995, Journal of gastroenterology and hepatology.

Immunohistochemical analysis on the expressions of maturation associated antigens, Fcγ receptors and CD14 in normal and diseased human liver macrophages

Kazuhide Yamamoto, T. Tsuji, H. Kobashi, 1994 .

Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab

M. Kurosaki, N. Izumi, H. Marusawa, 2022, Investigational New Drugs.

Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5‐year study of patients with hepatitis B with lamivudine resistance

A. Takaki, Kazuhide Yamamoto, Y. Takeuchi, 2012, Journal of medical virology.

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

M. Kurosaki, N. Izumi, T. Sohda, 2018, Journal of Gastroenterology.

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.

J. Toshimori, A. Takaki, Kazuhide Yamamoto, 2016, Acta Medica Okayama.

Lamivudine treatment improves the prognosis of fulminant hepatitis B.

Y. Shiratori, A. Takaki, Y. Miyake, 2008, Internal medicine.

Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis

Y. Shiratori, A. Takaki, Y. Miyake, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

A. Takaki, Kazuhide Yamamoto, F. Ikeda, 2015, Journal of medical virology.

Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B

M. Kurosaki, N. Izumi, H. Marusawa, 2022, Journal of medical virology.

Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients

Y. Shiratori, H. Shiraha, A. Takaki, 2006, Journal of Gastroenterology.

Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients

H. Shiraha, A. Takaki, Kazuhide Yamamoto, 2011, BMC Cancer.

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.

J. Toshimori, A. Takaki, Kazuhide Yamamoto, 2014, Acta medica Okayama.

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

H. Shiraha, A. Takaki, T. Yagi, 2011, Hepatology international.

Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure

N. Enomoto, M. Kurosaki, N. Izumi, 2016, PloS one.

Short-Term High-Dose Followed by Long-Term Low-Dose Hepatitis B Immunoglobulin and Lamivudine Therapy Prevented Recurrent Hepatitis B After Liver Transplantation

Y. Shiratori, N. Tanaka, A. Takaki, 2007, Transplantation.

A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis.

Jun Kato, Y. Shiratori, A. Takaki, 2007, Acta medica Okayama.

New Prognostic Scoring Model for Liver Transplantation in Patients with Non-Acetaminophen-Related Fulminant Hepatic Failure

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2005, Transplantation.

Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2

Y. Shiratori, Noriaki Aoki, Hironori Tanaka, 2011, Scandinavian journal of gastroenterology.

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2005, Journal of hepatology.

Acute hepatitis due to hepatitis E virus genotype 1 as an imported infectious disease in Japan.

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2010, Internal medicine.

A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response

M. Kurosaki, N. Izumi, H. Marusawa, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

J. Tani, Shinichiro Nakamura, K. Nouso, 2019, Liver Cancer.

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

Y. Shiratori, Y. Iwasaki, K. Takaguchi, 2004, Liver international : official journal of the International Association for the Study of the Liver.

Sepsis‐associated liver injury: Incidence, classification and the clinical significance

J. Toshimori, Kazuhide Yamamoto, H. Kobashi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Two cases of perforated duodenal diverticulum successfully treated using conservative therapy.

J. Toshimori, M. Ohmori, M. Inoue, 2017, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

A 27-year-old man who died of acute liver failure probably due to trichloroethylene abuse

A. Takaki, T. Yagi, M. Hanazaki, 2008, Journal of Gastroenterology.

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

Y. Shiratori, Y. Iwasaki, K. Takaguchi, 2006, Hepatology.

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

M. Kurosaki, N. Izumi, T. Sohda, 2021, Cancers.

Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

M. Kurosaki, N. Izumi, H. Marusawa, 2021, Journal of medical virology.

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.

H. Hagihara, A. Takaki, Y. Takeuchi, 2018, Acta medica Okayama.

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2006, Alimentary pharmacology & therapeutics.

Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis

Kazuhide Yamamoto, T. Yasunaka, H. Okada, 2012, Journal of gastroenterology and hepatology.

Hemostasis of gastric variceal hemorrhage by transileocoecal and transhepatic obliteration.

H. Kobashi, M. Omoto, T. Shiota, 1993, Acta medica Okayama.

Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen

M. Kurosaki, N. Izumi, T. Sohda, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray.

Y. Shiratori, Kazuhide Yamamoto, Y. Iwasaki, 2006, Translational research : the journal of laboratory and clinical medicine.

A primary diffuse large B-cell lymphoma of the liver treated with R-CHOP regimen

T. Yoshino, S. Fujii, M. Okazaki, 2015 .

Peritoneovenous shunting for refractory ascites results in worsening of nephrotic syndrome

A. Takaki, T. Yagi, Kazuhide Yamamoto, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

HEPATIC ANGIOSARCOMA WITH CHARACTERISTIC LAPAROSCOPIC FINDINGS

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2012, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

A Case of Funnel Liver Induced by Dimethylformamide

Kazuhide Yamamoto, T. Tsuji, T. Ito, 1992 .

Systemic IgG4-related disease with extensive peripheral nerve involvement that progressed from localized IgG4-related lymphadenopathy: an autopsy case

T. Yoshino, Yasuharu Sato, K. Hashimoto, 2014, Diagnostic Pathology.

Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group.

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical features of antinuclear antibodies‐negative type 1 autoimmune hepatitis

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma

M. Kudo, N. Izumi, Y. Shiratori, 2011, Hepatology.

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

M. Kurosaki, N. Izumi, H. Marusawa, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group

M. Kurosaki, N. Izumi, H. Marusawa, 2023, Investigational New Drugs.

Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma

M. Honda, H. Shiraha, K. Kuwaki, 2013, British Journal of Cancer.

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology international.

Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis

Y. Shiratori, Y. Miyake, Y. Iwasaki, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Nonsuppurative cholangitis is induced in neonatally thymectomized mice: A possible animal model for primary biliary cirrhosis

K. Yamamoto, H. Kobashi, M. Tomita, 1994, Hepatology.

Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival

Y. Shiratori, Hideki Ohnishi, Shinichiro Nakamura, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Peritoneoscopic Findings of Autoimmune Hepatitis

Kazuhide Yamamoto, N. Omori, T. Tsuji, 1994 .

A multicenter survey of enteroscopy for the diagnosis of intestinal follicular lymphoma.

K. Takata, T. Yoshino, M. Iwamuro, 2015, Oncology letters.

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response

M. Kurosaki, N. Izumi, H. Marusawa, 2023, JGH open : an open access journal of gastroenterology and hepatology.

Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis by Endoscopic Pancreatic Stenting after Insertion of Self-Expandable Metal Stent for Malignant Distal Biliary Stricture.

M. Inoue, H. Kobashi, R. Harada, 2020, Acta medica Okayama.

Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis.

Y. Shiratori, A. Takaki, Y. Miyake, 2007, Internal medicine.

Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis

M. Kurosaki, N. Izumi, Hyun-Yong Lee, 2023, Hepatology.